Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.01 USD
−10.15 M USD
0.00 USD
About Neuphoria Therapeutics Inc.
Sector
CEO
Spyridon Papapetropoulos
Headquarters
Burlington
Website
FIGI
BBG01RFZ8658
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NEUP is 4.03 USD — it has decreased by −32.88% in the past 24 hours. Watch Neuphoria Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Neuphoria Therapeutics Inc. stocks are traded under the ticker NEUP.
NEUP stock has risen by 41.00% compared to the previous week, the month change is a 30.90% rise, over the last year Neuphoria Therapeutics Inc. has showed a −76.01% decrease.
NEUP stock is 60.27% volatile and has beta coefficient of 4.81. Track Neuphoria Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Neuphoria Therapeutics Inc. there?
Today Neuphoria Therapeutics Inc. has the market capitalization of 13.87 B, it has increased by 2.43 K% over the last week.
Yes, you can track Neuphoria Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Neuphoria Therapeutics Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
No, NEUP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 28, 2024, the company has 24.00 employees. See our rating of the largest employees — is Neuphoria Therapeutics Inc. on this list?
Like other stocks, NEUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Neuphoria Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Neuphoria Therapeutics Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Neuphoria Therapeutics Inc. stock shows the sell signal. See more of Neuphoria Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.